194 related articles for article (PubMed ID: 8459988)
1. A review of ondansetron in the management of radiotherapy-induced emesis.
Roberts JT; Priestman TJ
Oncology; 1993; 50(3):173-9. PubMed ID: 8459988
[TBL] [Abstract][Full Text] [Related]
2. [Ondansetron in the prevention of radiation-induced nausea and emesis in patients treated with single-fraction irradiation].
Jeremić B
Srp Arh Celok Lek; 1996; 124(5-6):131-4. PubMed ID: 9102832
[TBL] [Abstract][Full Text] [Related]
3. Randomized double-blind, placebo-controlled evaluation of oral ondansetron in the prevention of nausea and vomiting associated with fractionated total-body irradiation.
Spitzer TR; Bryson JC; Cirenza E; Foelber R; Wallerstadt M; Stout C; Kunka RL; Plagge PB; Dubois A
J Clin Oncol; 1994 Nov; 12(11):2432-8. PubMed ID: 7964960
[TBL] [Abstract][Full Text] [Related]
4. Ondansetron for efficient emesis control during total body irradiation.
Schwella N; König V; Schwerdtfeger R; Schmidt-Wolf I; Schmid H; Riess H; Siegert W
Bone Marrow Transplant; 1994 Feb; 13(2):169-71. PubMed ID: 8205086
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy of ondansetron in radiation-induced nausea and vomiting: review of the literature].
Lévy E; Paillarse JM; Votan B
Bull Cancer Radiother; 1994; 81(3):179-85. PubMed ID: 7702901
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of an ondansetron orally disintegrating tablet: a novel oral formulation of this 5-HT(3) receptor antagonist in the treatment of fractionated radiotherapy-induced nausea and emesis. Emesis Study Group for the Ondansetron Orally Disintegrating Tablet in Radiotherapy Treatment.
LeBourgeois JP; McKenna CJ; Coster B; Feyer P; Franzén L; Goedhals L; Marzecki Z; Souhami L; Stewart A; Tønnessen F; Haigh C; Mitchell T; Wilkinson JR; Graham E
Clin Oncol (R Coll Radiol); 1999; 11(5):340-7. PubMed ID: 10591823
[TBL] [Abstract][Full Text] [Related]
7. A prospective randomized double-blind trial comparing ondansetron versus prochlorperazine for the prevention of nausea and vomiting in patients undergoing fractionated radiotherapy.
Priestman TJ; Roberts JT; Upadhyaya BK
Clin Oncol (R Coll Radiol); 1993; 5(6):358-63. PubMed ID: 8305355
[TBL] [Abstract][Full Text] [Related]
8. Double-blind, randomized, parallel-group study on the efficacy and safety of oral granisetron and oral ondansetron in the prophylaxis of nausea and vomiting in patients receiving hyperfractionated total body irradiation.
Spitzer TR; Friedman CJ; Bushnell W; Frankel SR; Raschko J
Bone Marrow Transplant; 2000 Jul; 26(2):203-10. PubMed ID: 10918432
[TBL] [Abstract][Full Text] [Related]
9. Radiation-induced emesis: effects of ondansetron.
Scarantino CW; Ornitz RD; Hoffman LG; Anderson RF
Semin Oncol; 1992 Dec; 19(6 Suppl 15):38-43. PubMed ID: 1485181
[TBL] [Abstract][Full Text] [Related]
10. [Ondansetron in the prophylaxis of acute emesis induced by supra-high single dose total body irradiation (TBI)].
Huang X; Guo N; Fan Y
Zhonghua Zhong Liu Za Zhi; 1995 Jan; 17(1):64-6. PubMed ID: 7656793
[TBL] [Abstract][Full Text] [Related]
11. Ondansetron: a review of its use as an antiemetic in children.
Culy CR; Bhana N; Plosker GL
Paediatr Drugs; 2001; 3(6):441-79. PubMed ID: 11437189
[TBL] [Abstract][Full Text] [Related]
12. Ondansetron as prophylaxis for chemotherapy and radiotherapy-induced emesis in children.
Jürgens H; McQuade B
Oncology; 1992; 49(4):279-85. PubMed ID: 1387928
[TBL] [Abstract][Full Text] [Related]
13. A randomised placebo controlled study with ondansetron in patients undergoing fractionated radiotherapy.
Franzén L; Nyman J; Hagberg H; Jakobsson M; Sorbe B; Nyth AL; Lomberg H; Henriksson R
Ann Oncol; 1996 Aug; 7(6):587-92. PubMed ID: 8879372
[TBL] [Abstract][Full Text] [Related]
14. Ondansetron plus dexamethasone compared to the 'standard' metoclopramide combination.
Roila F
Oncology; 1993; 50(3):163-7. PubMed ID: 8459986
[TBL] [Abstract][Full Text] [Related]
15. Ondansetron. An update of its therapeutic use in chemotherapy-induced and postoperative nausea and vomiting.
Markham A; Sorkin EM
Drugs; 1993 Jun; 45(6):931-952. PubMed ID: 7691500
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of oral ondansetron versus prochlorperazine in the prevention of emesis associated with cyclophosphamide-based chemotherapy and maintenance of health-related quality of life.
Crucitt MA; Hyman W; Grote T; Tester W; Madajewicz S; Yee S; Wentz A; Griffin D; Parasuraman TV; Bryson J
Clin Ther; 1996; 18(3):508-18. PubMed ID: 8829027
[TBL] [Abstract][Full Text] [Related]
17. Results of a double blind placebo controlled study of ondansetron as an antiemetic during total body irradiation in patients undergoing bone marrow transplantation.
Tiley C; Powles R; Catalano J; Treleaven J; Eshelby J; Hewetson M; Tait D; Cunningham D
Leuk Lymphoma; 1992 Jul; 7(4):317-21. PubMed ID: 1493431
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of oral ondansetron versus prochlorperazine in the prevention of emesis associated with cyclophosphamide-based chemotherapy and maintenance of health-related quality of life.
Crucitt MA; Hyman W; Grote T; Tester W; Madajewicz S; Yee S; Wentz A; Griffin D; Parasuraman TV; Bryson J
Clin Ther; 1996; 18(4):778-88. PubMed ID: 8879903
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of ondansetron against emesis induced by a multiple-day cisplatin-based chemotherapy regimen for malignant lymphoma.
Kamiya T; Sakurai M; Kikuchi T; Okayama M; Mizuno K; Tanigawa T; Koda Y; Kato J; Mori T
Hematology; 2021 Dec; 26(1):945-949. PubMed ID: 34789076
[TBL] [Abstract][Full Text] [Related]
20. Role of ondansetron plus dexamethasone in fractionated chemotherapy.
Räth U; Upadhyaya BK; Arechavala E; Böckmann H; Dearnaley D; Droz JP; Fosså SD; Henriksson R; Aulitzky WE; Jones WG
Oncology; 1993; 50(3):168-72. PubMed ID: 8459987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
